Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

COVID-19 impacts cardiac care in the United Kingdom

Postponing non-urgent cardiac care and surgeries because of COVID-19 will likely increase demand for cardiac care along with increased costs.

4 Dec 2020

Public willingness to take a COVID-19 vaccine around the globe: Study

The worldwide impact of the COVID-19 pandemic led to an unprecedented effort to develop vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on a timescale that has never been imagined before. Even as some vaccines have begun to be administered on a large scale, scientists and governments are coming up against a difficult obstacle.

3 Dec 2020

Lessons from Italian neurosurgeons who fought on the frontline of COVID-19 pandemic's first wave

A report by neurosurgeons at the Papa Giovanni XXIII Hospital in Bergamo, Italy, highlights the strategies their unit had to take to help combat the viral illness, which has claimed the lives of more than 1.49 million people worldwide. The study was published in the Journal of Neurosurgery in December 2020.

3 Dec 2020

Can melatonin help prevent severe COVID-19?

A team of researchers at the University of Toronto in Canada has found that melatonin can be an adjuvant to augment the efficacy of anti-SARS-CoV-2 vaccines. They believe that the drug is a potential “silver bullet” to combat the COVID-19 pandemic.

3 Dec 2020

Household composition and ethnicity may contribute to higher COVID-19 mortality: a UK case study

A new study by researchers in the UK found that older people living with relatives are at an increased risk of severe COVID-19 and death. They also revealed that living in a multi-generational household, where extended family members live, was tied to increased COVID-19 mortality.

3 Dec 2020

High seroprevalence of short-lived anti-SARS-CoV-2 antibodies in Paris

A recent study indicates a high seroprevalence of antibodies against SARS-CoV-2 among individuals working in a Paris-based institute.

3 Dec 2020

Designed proteins assemble antibodies into modular nanocages

With cues from nature, designing functional molecules enables scientists to nanoengineer and customize for specific uses.

3 Dec 2020

Nanoparticles with neutralizing antibodies can inactivate SARS-CoV-2

Using nanoparticles conjugated with SARS-CoV-2 neutralizing antibodies, researchers demonstrated that intense local heating could inactivate the virus.

3 Dec 2020

Pomegranate extract could inhibit the virus that causes COVID-19

Researchers have conducted a study demonstrating the potential antiviral effects of pomegranate extract against SAR-CoV-2.

3 Dec 2020

Novel “multitope” vaccine shows promise in the fight against COVID-19

Researchers have demonstrated the potential of a protein-peptide vaccine to protect against infection with SARS-CoV-2, the agent that causes COVID-19.

3 Dec 2020

New insight into role of autophagy in controlling SARS-CoV-2 infection

A team of researchers at the University of Manitoba in Canada said that nanoparticle targeting of autophagy at the sites could be a potent tool to effectively overcome COVID-19 while preventing the common adverse effects of the drug.

2 Dec 2020

Emergence of new zoonotic infections like SARS-CoV-2 is inevitable

A team of researchers at the ICAR-Indian Veterinary Research Institute explored the role of animals, the veterinary, and associated zoonotic links of SARS-CoV-2 and prevention and control strategies based on 'One Health' approaches. The research is published in the journal Veterinary Quarterly.

2 Dec 2020

The UK approves Pfizer vaccine for December 2020 roll out

The UK approves Pfizer vaccine and schedules phased vaccination process, commencing December 2020.

2 Dec 2020

Spanish-originated SARS-CoV-2 variant A222V shows rapid spread in Lazio, Italy

A startling new study reports the rapid rise to dominance of a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain in Italy. This strain, termed the GV clade, is characterized by a single point mutation.

2 Dec 2020

New and sudden headaches may be a symptom of COVID-19

Researchers report a case of a young male patient who came in with a headache to an emergency room. He had increased intracranial pressure and tested positive for SARS-CoV-2, suggesting new headaches during the pandemic should not be ignored.

2 Dec 2020

Scientists detect a sarbecovirus phylogenetically related to SARS-CoV-2 from bats in Japan

A team of researchers at the University of Tokyo in Japan have detected a sarbecovirus, called Rc-o319, which is phylogenetically positioned in the same clade as SARS-CoV-2 in Rhinolophus cornutus bats in Japan.

2 Dec 2020

Particulate matter levels can play a significant role in SARS-CoV-2 transmission

A new study has found that particulate matter (PM) plays a role in providing surfaces for SARS-CoV-2 transmission and interaction, enabling fomite transmission through deposition.

2 Dec 2020

SARS-CoV-2 deletion mutations may have attenuated infectivity in some strains

A team of researchers at the University of Hong Kong has identified a panel of SARS-CoV-2 variants, called Del-mut, which contains a deletion in the S1/S2 junction. Upon investigating one of the deleted variants in animal models, they found that Del-mut-1 is attenuated in its ability to cause disease or pathological changes.

2 Dec 2020

New, improved probes could make it easier to validate rapid COVID-19 diagnostic tests

Nanoengineers at the University of California San Diego have developed new and improved probes, known as positive controls, that could make it easier to validate rapid, point-of-care diagnostic tests for COVID-19 across the globe.

2 Dec 2020

PTC299 inhibits SARS-CoV-2 replication and suppresses production of inflammatory cytokines

In an article published in the journal Virus Research, a team of researchers from various US institutions discussed their study that evaluated the antiviral activity of PTC299 against a group of RNA viruses in vitro.

1 Dec 2020